MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

22 Jul 2022 Evaluate
The Sales for the quarter ended June 2022 of Rs. 123.66 millions rose by 25.02% from Rs. 98.91 millions.A humble growth in net profit of 7.87% reported in the quarter ended June 2022 to Rs. 37.71  millions from Rs. 34.96 millions.Operating profit for the quarter ended June 2022 rose to 71.37 millions as compared to 56.84 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 123.66 98.91 25.02 123.66 98.91 25.02 365.65 224.45 62.91
Other Income 0.48 0.70 -31.43 0.48 0.70 -31.43 6.29 4.08 54.17
PBIDT 71.37 56.84 25.56 71.37 56.84 25.56 180.90 67.89 166.46
Interest 1.12 4.64 -75.86 1.12 4.64 -75.86 12.15 15.48 -21.51
PBDT 70.25 52.20 34.58 70.25 52.20 34.58 168.75 52.41 221.98
Depreciation 17.86 17.24 3.60 17.86 17.24 3.60 69.74 64.56 8.02
PBT 52.39 34.96 49.86 52.39 34.96 49.86 99.01 -12.15 -914.90
TAX 14.68 0.00 0.00 14.68 0.00 0.00 -122.75 0.00 0.00
Deferred Tax 14.68 0.00 0.00 14.68 0.00 0.00 -122.75 0.00 0.00
PAT 37.71 34.96 7.87 37.71 34.96 7.87 221.76 -12.15 -1925.19
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 57.71 57.47 0.43 57.71 57.47 0.43 49.47 30.25 63.56
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..